Director, Cardiac Cath Lab, PERT, & Structural Heart
Manatee Memorial Hospital
Dr. Mathews is an interventional cardiologist and endovascular specialist at Bradenton Cardiology Center in Bradenton, FL specializing in complex coronary interventions, structural heart procedures, endovascular therapies, and novel device research. He did graduate and professional training at Tufts University in Boston, MA where he received his MD and Master's in Health Communication at the Sackler School of Biomedical Sciences focusing on telemedicine and interactive education. He completed residency training and fellowship training in Cardiovascular Disease, Advanced Cardiac Imaging, and Interventional Cardiology at the Washington University School of Medicine in St. Louis, MO. He is currently national primary investigator in several trials and is actively involved in endovascular research.
Disclosure(s): Abbott: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Akura Medical: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Bolt Medical: Consultant/Advisory Board (Ongoing); Boston Scientific: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Cardiva: Consultant (Ongoing), Speakers' Bureau (Ongoing); CONTEGO MEDICAL: Clinical Trial Support (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Cordis, Endovascular Division: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Endologix: Consultant (Ongoing); Evident Vascular: Consultant/Advisory Board (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Innova vascular: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Inquis: Consultant (Ongoing); Penumbra, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Philips Medical: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speakers' Bureau (Ongoing); Protexa: Advisory Committee/Board Member (Ongoing), Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); Reflow Medical: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing), Stock Shareholder (excluding mutual funds) (Ongoing); Shockwave: Consultant (Ongoing), Speakers' Bureau (Ongoing)
CARDIOTUBE INTERVIEW - Retrievable Stent Therapy: The Temporary Spur Stent System Platform
Monday, March 11, 2024
10:00 AM – 10:15 AM ET
VESSEL PREP, BALLOONS AND STENTS
Monday, March 11, 2024
6:15 AM – 8:00 AM ET
Monday, March 11, 2024
12:30 PM – 1:45 PM ET
Welcome & Faculty Introductions
Monday, March 11, 2024
12:45 PM – 12:50 PM ET
Lightning Flash Technology Overview & Case Presentations
Monday, March 11, 2024
1:05 PM – 1:20 PM ET
Monday, March 11, 2024
1:40 PM – 1:45 PM ET
DIAGNOSIS AND MANAGEMENT OF PULMONARY EMBOLISM
Monday, March 11, 2024
2:00 PM – 3:30 PM ET
Monday, March 11, 2024
3:12 PM – 3:30 PM ET
Have COMPASS & VOGERY Trials Really Changed Our Practice?
Monday, March 11, 2024
3:46 PM – 3:54 PM ET
Novel Approaches to Thrombectomy
Monday, March 11, 2024
4:58 PM – 5:06 PM ET
Panel Discussion | Recap of Session
Monday, March 11, 2024
5:06 PM – 5:30 PM ET
Retrievable Stent Therapy: The Temporary Spur Stent System Platform
Monday, March 11, 2024
4:50 PM – 4:58 PM ET